840P Electronic patient-reported outcomes (ePROs) of adults with BRAF V600–mutant stage III-IV melanoma treated with dabrafenib + trametinib (D + T) collected using the Kaiku Health digital patient (pt) monitoring platform

Autor: Lijnsvelt, J., Addeo, A., Vitale, M.G., Mohr, P., Queirolo, P., Ekström, J., Vainio, J., Kataja, V.V., Calado, F., Fagan, A., Lau, M.R., Romero Salas, T., Thole-Glettig, H., Blank, C.U., Ascierto, P.A.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S933-S934
Databáze: ScienceDirect